Educators

This information sheet  provides a comprehensive overview of tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis that primarily affects the lungs but can involve other parts of the body. It distinguishes between Latent TB Infection (LTBI), which is asymptomatic and non-infectious, and active TB disease, which can be pulmonary (infectious) or extrapulmonary (non-infectious).

Recent weeks have seen a handful of new Tuberculosis (TB) cases reported in states including Maine, North Carolina and California. While TB is rare in the U.S., even a single active case warrants attention. This article provides an overview of what TB is & how it spreads. TB is caused by a bacterium (Mycobacterium tuberculosis) that typically attacks the lungs, forming lesions called “tubercles,” and can destroy lung tissue — severe disease can lead to respiratory failure.

This article reviews key clinical and public health considerations surrounding recent tuberculosis (TB) cases reported in Maine, North Carolina, and California. Although TB remains relatively rare in the United States, it continues to cause more than 1 million deaths annually worldwide and poses ongoing risks, particularly for individuals with weakened immune systems or those who live or work in congregate settings.

This webinar session, Tuberculosis: A Disease Neglected, Misunderstood, but Deadly, provides a comprehensive overview of TB’s microbiology, pathophysiology, and current epidemiology, along with effective strategies for public health prevention and clinical management. Facilitated by Gavin Harris, MD (Emory University), the program features didactic instruction from Marcos C.

GLP-1 receptor agonists (GLP-1s), including semaglutide, tirzepatide, and liraglutide, are increasingly used for weight management and show promise for people living with HIV (PLWH). While these medications are generally safe, PLWH may face additional considerations when using them due to how GLP-1s function and interact with antiretroviral therapy (ART). GLP-1s slow gastric emptying and suppress appetite, which may affect ART absorption; gastrointestinal side effects such as nausea or vomiting may also interfere with consistent ART dosing.

This infographic from Fair Health draws on data from its NPIC database—over 47 billion commercial medical and dental claims—to highlight rising trends in sexually transmitted disease (STD) diagnoses across various demographics in the U.S. between 2020 and 2023. The visuals show that overall STD diagnoses increased significantly, led by notable rises in syphilis, gonorrhea, and HIV/AIDS.

Tuberculosis (TB) remains the world’s deadliest infectious disease and a major treatment challenge, especially in cases resistant to standard therapies. A new AI-powered tool developed by Tufts University researchers, called DECIPHAER (Decoding Cross-Modal Information of Pharmacologies via Autoencoders), seeks to advance TB treatment by elucidating exactly how drugs kill the bacterium at the cellular and molecular levels.

Tuberculosis (TB), a contagious bacterial infection primarily affecting the lungs, remains a health risk in the U.S. Though cases declined for decades, recent increases — including ~10,347 cases in early data from 2024 — suggest testing and treatment of latent TB is needed more than ever.  Testing is crucial both for diagnosing latent TB (where bacteria are present but symptoms are absent) and active TB disease (which is contagious and manifests symptoms).

This video explains the role of Pap smears in cervical health, highlighting that while they detect abnormal cell changes, they do not test for most STDs. It focuses on the connection between Pap smears and human papillomavirus (HPV), which is related to cervical cancer. The video emphasizes the importance of understanding the limitations of Pap smears and encourages discussing STD concerns with your healthcare provider for comprehensive testing.